Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Modeling Parkinson's disease in monkeys for translational studies, a critical analysis.

Potts LF, Wu H, Singh A, Marcilla I, Luquin MR, Papa SM.

Exp Neurol. 2014 Jun;256:133-43. doi: 10.1016/j.expneurol.2013.09.014. Epub 2013 Sep 23. Review.

2.

Dyskinesias do not develop after chronic intermittent levodopa therapy in clinically hemiparkinsonian rhesus monkeys.

Lieu CA, Deogaonkar M, Bakay RA, Subramanian T.

Parkinsonism Relat Disord. 2011 Jan;17(1):34-9. doi: 10.1016/j.parkreldis.2010.10.010. Epub 2010 Nov 11.

3.

Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson's disease.

Quik M, Mallela A, Ly J, Zhang D.

Mov Disord. 2013 Sep;28(10):1398-406. doi: 10.1002/mds.25594. Epub 2013 Jul 8.

4.

Modeling dyskinesia in animal models of Parkinson disease.

Morin N, Jourdain VA, Di Paolo T.

Exp Neurol. 2014 Jun;256:105-16. doi: 10.1016/j.expneurol.2013.01.024. Epub 2013 Jan 27. Review.

PMID:
23360802
6.

Investigating levodopa-induced dyskinesias in the parkinsonian primate.

Langston JW, Quik M, Petzinger G, Jakowec M, Di Monte DA.

Ann Neurol. 2000 Apr;47(4 Suppl 1):S79-89. Review.

PMID:
10762135
7.
8.

AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces l-Dopa-induced dyskinesias and extends the duration of l-Dopa effects in parkinsonian monkeys.

Di Paolo T, Grégoire L, Feuerbach D, Elbast W, Weiss M, Gomez-Mancilla B.

Parkinsonism Relat Disord. 2014 Nov;20(11):1119-23. doi: 10.1016/j.parkreldis.2014.05.007. Epub 2014 May 22.

PMID:
25172125
9.

The effects of fast-off-D2 receptor antagonism on L-DOPA-induced dyskinesia and psychosis in parkinsonian macaques.

Koprich JB, Huot P, Fox SH, Jarvie K, Lang AE, Seeman P, Brotchie JM.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:151-6. doi: 10.1016/j.pnpbp.2012.12.008. Epub 2013 Jan 7.

PMID:
23306217
10.

Rest tremor in rhesus monkeys with MPTP-induced parkinsonism.

Emborg ME, Tetrud JW, Moirano J, McLaughlin WW, Bankiewicz KS.

Front Biosci. 2003 May 1;8:a148-54.

PMID:
12700090
11.

Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.

Oiwa Y, Eberling JL, Nagy D, Pivirotto P, Emborg ME, Bankiewicz KS.

Front Biosci. 2003 Sep 1;8:a155-66.

PMID:
12957824
12.

Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.

Di Monte DA, McCormack A, Petzinger G, Janson AM, Quik M, Langston WJ.

Mov Disord. 2000 May;15(3):459-66.

PMID:
10830409
13.

Combined fenobam and amantadine treatment promotes robust antidyskinetic effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned primate model of Parkinson's disease.

Ko WK, Pioli E, Li Q, McGuire S, Dufour A, Sherer TB, Bezard E, Facheris MF.

Mov Disord. 2014 May;29(6):772-9. doi: 10.1002/mds.25859. Epub 2014 Mar 7.

PMID:
24610195
14.

Developing a stable bilateral model of parkinsonism in rhesus monkeys.

Smith RD, Zhang Z, Kurlan R, McDermott M, Gash DM.

Neuroscience. 1993 Jan;52(1):7-16.

PMID:
8433810
15.
16.

Synergistic antidyskinetic effects of topiramate and amantadine in animal models of Parkinson's disease.

Kobylecki C, Hill MP, Crossman AR, Ravenscroft P.

Mov Disord. 2011 Nov;26(13):2354-63. doi: 10.1002/mds.23867. Epub 2011 Sep 23.

PMID:
21953539
17.

The highly-selective 5-HT(1A) agonist F15599 reduces L-DOPA-induced dyskinesia without compromising anti-parkinsonian benefits in the MPTP-lesioned macaque.

Huot P, Johnston TH, Fox SH, Newman-Tancredi A, Brotchie JM.

Neuropharmacology. 2015 Oct;97:306-11. doi: 10.1016/j.neuropharm.2015.05.033. Epub 2015 Jun 10.

PMID:
26071982
18.
19.

Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease.

Fidalgo C, Ko WK, Tronci E, Li Q, Stancampiano R, Chuan Q, Bezard E, Carta M.

Neuroscience. 2015 Jul 9;298:389-96. doi: 10.1016/j.neuroscience.2015.04.027. Epub 2015 Apr 20.

PMID:
25907446
20.

Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias.

Ouattara B, Hoyer D, Grégoire L, Morissette M, Gasparini F, Gomez-Mancilla B, Di Paolo T.

Neuroscience. 2010 Jun 2;167(4):1160-7. doi: 10.1016/j.neuroscience.2010.03.022. Epub 2010 Mar 18.

PMID:
20303391

Supplemental Content

Support Center